Status:
UNKNOWN
Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease
Lead Sponsor:
Centre Hospitalier le Mans
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prevalence of peripheral arterial disease is 12.2% in France. Intermittent claudication is the most common symtom of this disease. During physical exercise, such as walking, blood oxygen (O2) requ...
Eligibility Criteria
Inclusion
- Patient with Lower Limb Peripheral Arterial Disease with IPSC \< 0.90, arterial stenosis in the lower limbs and intermittent claudication
- No contraindication to physical activity
Exclusion
- Severe or unstable cardiopulmonary pathologies, contraindicating exercise training
- Unstable angina or myocardial infarction \<3 months
- Severe rheumatological pathology of the lower limbs
- Amputee of a lower or upper limb fitted with a device
- Extensive dermatosis of the lower limbs
- Known NYHA grade III or IV heart failure
- Known severe respiratory pathology
- Parkinson's disease, hemiplegia or paraplegia
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04800276
Start Date
February 1 2021
End Date
February 1 2023
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Du Mans
Le Mans, France, 72000